MedRythyms – a Portland-based digital therapeutics company has signed a lucrative deal with pharmaceutical giant Biogen to bring its music therapy offering designed to improve walking in people with multiple sclerosis a step closer to reality.
Subscribe to:
Post Comments (Atom)
< + > Provider Enrollment is a Data Problem Hiding in the Denial Queue
The following is a guest article by Madison Gardner, President at AMS Solutions, Inc. A claim can pass every check a practice controls and ...
No comments:
Post a Comment